Investing in a Better Future
Empowering Growth with Long-Term Capital
Investing in a
Better Future
Empowering Growth with Long-Term Capital
About Us
“Patience isn’t passive, it’s the most active part of good investing”
For over 100 years, the Bagaria family has built and grown businesses that serve global partners with trust, precision, and long-term vision. From its beginnings in Assam to becoming a respected global contract manufacturer for leading pharmaceutical companies, they have been defined by two values: patient building and uncompromising integrity.
Kemfin Family Office, the investment arm of Karan Bagaria, carries these same principles into investing. We are not guided by market cycles or short-term trends, but by the belief that thoughtful capital, deployed with discipline and patience, creates lasting impact. Our mandate spans multiple asset classes—public and private equity, venture, credit, and real assets—but our philosophy remains constant: invest where we can build durable value.
Partnership is at the heart of what we do. We prefer to co-invest with trusted families, entrepreneurs, and managers who share our outlook. For us, success is measured not just in financial returns, but in the quality of relationships we build and the resilience of the platforms we help create.
Our
Our People
Our Leaders
.
Our Leaders
.
Our Leaders
.
Our Leaders
.
Our Leaders
.
Our Leaders
.
Our Leaders
.
Our Leaders
.
Our Leaders
.
Our Leaders
.
-
Karan Bagaria
Promoter and Managing Director
Karan Bagaria
Karan holds a BS in Business Administration from Boston University and an MBA from Babson College.
As a second-generation entrepreneur, Karan began his career at Millipore (now Merck KGaA) in Boston, where he worked for a few years supporting the company’s international operations and life sciences R&D teams. He then moved to Millipore India in 2009, where he played a crucial role in selling his family’s stake of 60% to Millipore USA.
After completing his MBA in 2011, Karan joined Kemwell Biopharma as Head of Corporate and Business Development, where he helped increase Kemwell’s global sales to over $100 million adding new technologies, markets and MNC customers. He led the R&D business and grew that to a 200+ member team globally including completing an acquisition of a CRO Lab in Research Triangle Park, NC, USA. In 2016, he led the demerger of Kemwell’s small molecule pharmaceutical business and successfully completed , a strategic sale to Recipharm, Sweden.
Karan’s journey highlights his deep expertise in business development, strategic transactions, and his leadership in growing family-owned businesses into global plays.
-
Pranshu Mittal
Chief Investment Office
Pranshu Mittal
Pranshu Mittal spearheads the investment function at Kemfin, where he is responsible for building and executing robust investment strategies and policies for the Family Office. He brings over 20 years of experience in multi-asset portfolio management, with deep expertise across public equity, private equity, and structured credit.
Prior to joining Kemfin, Pranshu was with the Patni Family Office, where he successfully managed, scaled the public equities portfolio, and played an active role in private equity and structured debt transactions.
-
Jainis Chheda
Investment Manager
Jainis Chheda
Jainis is an accomplished investment research professional with a decade long experience in Equity Research and Investment Banking. He has previously worked with Spark PWM and Singhi Advisors. He is a CA by profession.
-
Aayushi Shah
Investment Manager
Aayushi Shah
Aayushi has over five years experience in Venture Capital and Investment Banking. She has previously worked with ITI Growth Opportunities Fund and MGB Advisors. She holds an MSc in Finance from NMIMS, Mumbai.
-
Suresh Ganachari
CFO
Suresh Ganachari
Suresh is a seasoned finance professional with over 28 years of comprehensive experience in leading financial operations, Implementing Strategic initiatives, and driving sustainable business growth. He has a proven track record of optimizing financial performance, enhancing operational efficiency alongside instrumenting M&As, Compliance and Corporate Governance, ERP Implementation, and Fund raising for new projects. He has previously worked with leading Pharma, Automobile, Software and Telecom companies. Suresh is a CA, CMA and CS by profession.
Our
Investment Strategy
The family office adopts a disciplined, multi-asset investment strategy with a long-term horizon.
The office focuses on identifying differentiated opportunities with asymmetric upside, particularly across:
Public Equities
(Listed Markets)
A dual-pronged approach: Actively investing in public markets and fueling growth-stage capital for next-gen small & mid-cap companies
Private Equity
(Growth Capital)
Established LP Positions and Credit Markets exposure in Prominent Funds.
Credit Markets exposure through prominent funds including
Credit Markets exposure through prominent funds including
